US Stock MarketDetailed Quotes

GDRX GoodRx

Watchlist
  • 6.850
  • -0.060-0.87%
Trading Oct 15 10:23 ET
2.60BMarket Cap-48928P/E (TTM)

GoodRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GoodRx Q3 2024 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
195.65M
+8.72%
EPS
0.02
+126.92%
Analyst Rating
Buy

Oct 15, 2024

GoodRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 206.280M--
Nov 7, 20242024/Q3-- / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--
Feb 29, 20242023/Q4196.644M / 195.873M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 206.280M--
Nov 7, 20242024/Q3-- / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--
Feb 29, 20242023/Q4196.644M / 195.873M--

Unlock Free Earnings Estimates

GoodRx Earnings Reports

  • GoodRx | 10-Q: Q2 2024 Earnings Report

    Aug 8 13:19 ET

  • GoodRx | 10-Q: Q1 2024 Earnings Report

    May 9 15:58 ET

  • GoodRx | 10-K: FY2023 Annual Report

    Feb 29 14:09 ET

  • GoodRx | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 14:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 15, 2024

    Buy

    • Buy

      53.85%

    • Hold

      38.46%

    • Sell

      7.69%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data